Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

about

Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.Side effects associated with current and prospective antimigraine pharmacotherapies.The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.

P2860

Q38598006-B49CBD0B-D0C2-41EA-8C79-9394B1CDEDEC Q47309054-9FB03197-E55E-4C4D-B639-EB22688BF965 Q52608146-7291E06F-D6CA-46FE-A662-F7840022DB3B

P2860

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

Item

http://www.wikidata.org/entity/Q39242677

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@en

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@nl

type

Item

label

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@en

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@nl

prefLabel

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@en

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@nl

P1476

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

@en

P2093

Lanfranco Pellesi

http://www.w3.org/2001/XMLSchema#string

Luigi Alberto Pini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Prevalence of headache in Europe: a review for the Eurolight project

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

Migraine and cardiovascular disease: systematic review and meta-analysis

Immunotoxicity of monoclonal antibodies

BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)

CGRP may play a causative role in migraine

Calcitonin gene-related peptide: physiology and pathophysiology

Neuropeptides in migraine and cluster headache

Calcitonin gene-related peptide is a potent vasodilator

An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress

P304

534-547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/CPDD.345

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simona Guerzoni

P5008

ScienceSource

P577

2017-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28409893

http://www.w3.org/2001/XMLSchema#string

P921

nerve tissue proteins

P932

5697612

http://www.w3.org/2001/XMLSchema#string

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

about

P2860

P2860

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932